Evidence map›Paper›PMID 11242085›Full record

ArticleNature2001

Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans.

H A Tissenbaum, L Guarente

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 801 papers.

0numbers the graph read from it
0cells of the map it votes in
801citing papers in PubMed
16.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

801 citing papers in PubMed, 1,906 citations in OpenAlex.

  1. SIRT1: Protean roles at the nexus of health, disease, and therapeutics.Journal of cell communication and signaling · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Metabolic Biomarkers for Lifespan Extension and Cellular Stress inPreventive nutrition and food science · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

741 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

H A TissenbaumDepartment of Biology, Massachusetts Institute of Technology, Cambridge 02139, USA.
L Guarente
Massachusetts Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Caenorhabditis elegans, mutations that reduce the activity of an insulin-like receptor (daf-2) or a phosphatidylinositol-3-OH kinase (age-1) favour entry into the dauer state during larval development and extend lifespan in adults. Downregulation of this pathway activates a forkhead transcription factor (daf-16), which may regulate targets that promote dauer formation in larvae and stress resistance and longevity in adults. In yeast, the SIR2 gene determines the lifespan of mother cells, and adding an extra copy of SIR2 extends lifespan. Sir2 mediates chromatin silencing through a histone deacetylase activity that depends on NAD (nicotinamide adenine dinucleotide) as a cofactor. We have surveyed the lifespan of C. elegans strains containing duplications of chromosomal regions. Here we report that a duplication containing sir-2.1-the C. elegans gene most homologous to yeast SIR2-confers a lifespan that is extended by up to 50%. Genetic analysis indicates that the sir-2.1 transgene functions upstream of daf-16 in the insulin-like signalling pathway. Our findings suggest that Sir2 proteins may couple longevity to nutrient availability in many eukaryotic organisms.

Indexed as

Caenorhabditis elegans ProteinsSilent Information Regulator Proteins, Saccharomyces cerevisiaeAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansChromosome MappingFemaleForkhead Transcription FactorsGene DosageGene DuplicationGenes, FungalHelminth ProteinsHistone DeacetylasesLongevityMaleSignal TransductionCaenorhabditis elegans Proteinsdaf-16 protein, C elegansForkhead Transcription FactorsHelminth ProteinsHistone DeacetylasesSilent Information Regulator Proteins, Saccharomyces cerevisiaeSIR2 protein, S cerevisiaeSirtuin 2SirtuinsTrans-ActivatorsTranscription Factors

Identifiers

PMID11242085
OpenAlexW1985308585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.